SIRONA 2 Trial Heart Failure NYHA Class III
NCT: NCT04012944 · ACTIVE_NOT_RECRUITING
NCT IDNCT04012944
StatusACTIVE_NOT_RECRUITING
Start Date2019-06-26
Completion2027-07
Brief Summary
This is a prospective, multi-center, open-label, single-arm CE-Mark trial to assess device safety and efficacy of the Cordella PA Sensor System in up to 75 New York Heart Association (NYHA) Class III Heart Failure patients who will receive the Cordella PA Sensor Implant.
Frequently Asked Questions
What is SIRONA 2 Trial Heart Failure NYHA Class III?
SIRONA 2 Trial Heart Failure NYHA Class III is a clinical trial registered under NCT04012944. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT04012944?
The current status of NCT04012944 (SIRONA 2 Trial Heart Failure NYHA Class III) is: ACTIVE_NOT_RECRUITING.
When did SIRONA 2 Trial Heart Failure NYHA Class III start?
SIRONA 2 Trial Heart Failure NYHA Class III started on 2019-06-26.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.